EFFECTS OF NOVEL CORONAVIRUS DISEASE-19 (COVID-19) ON VITAL ORGANS IN PATIENTS INFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2)
Authors: Hossain M. Ibrahim , Shahriar Esha Binte , Sarker Anamika , Lubna Nafisa , Haque Mehjabeen , Khalil Md. Ibrahim 
Published: May 2021

The world is now facing one of the most devastating public health concern where the 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is spreading all over the world initiating from Wuhan, China, started from December, 2019. The World Health Organization (WHO) already announced the situation as pandemic all over the world. According to the webpage of WHO, this SARS-CoV-2 has been spreading all over the world (223 countries, areas or territories) with 126,890,643 of confirmed cases and 2,778,619 of confirmed deaths(as time of March 30, 2021). Accumulated published documents indicate that the SARS-CoV-2 virus primarily affects the lungs causing hypoxia which is the leading cause of death. There are many reports describing that with the progress of this disease, many other organs (such as heart, kidney, liver, brain) of the affected person start to malfunction. Though SARS-CoV-2 uses the cell surface receptor angiotensin-converting enzyme 2 (ACE-2) expressed by lungs, cardiovascular system, kidneys but it is still not clear except lungs all these other organs are directly affected by this virus or not. Therefore, the aim of this review is to gather information about the affected/damaged organs or tissues and the consequences of this damage in the COVID-19 patients.
                  
Peer Review History:
Received 11 March 2021; Revised 8 April; Accepted 23 April, Available online 15 May 2021
UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. 
Received file:                Reviewer's Comments:
Average Peer review marks at initial stage: 6.0/10
Average Peer review marks at publication stage: 7.0/10
Reviewer(s) detail:
Dr. Vanina Doris Edo’o,
University of Yaounde I, Yaounde, Cameroun, vanina_edoo@yahoo.com
Idoko Alexander,
Caritas University, Enugu, Nigeria, idokoalexander1@gmail.com
Similar Articles:
COVID-19: PHARMACOLOGICAL AND THERAPEUTIC APPROACHES
USE OF COLCHICINE TO COUNTERACT THE STRONG HYPERINFLAMMATORY STATE INDUCED BY SARS-COV-2
THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT